ChatGPTClaudeCursorGemini
The only franchise database you can use inside ChatGPT, Claude & Cursor. Learn more →

1,700+ FDDs structured for franchise professionals

We extract fees, Item 19 financials, franchisee contacts, SBA default rates, litigation, and outlet data from every FDD — so you can compare brands in minutes, not months. Used by multi-unit operators, consultants, and franchise development teams.

NexGenEsis Healthcare

NexGenEsis Healthcare

NexGenEsis Healthcare franchises operate physician-supervised clinics providing non-surgical, non-opioid pain relief, injury rehabilitation, and neuropathy treatments using autologous therapies such as platelet-rich plasma, alpha 2 macroglobulin, and bone marrow aspirate injections to enhance natural healing. Some locations also offer treatments for weight loss, hair loss, and erectile dysfunction. The business model includes standard franchises, conversions for existing medical businesses, bolt-on add-ons, and area development opportunities, targeting aging adults and athletes in a competitive regenerative medicine market.

6locations
$168K–$363K
Since 2022
ServicesHouston, TXEAD NexGenix LLCwww.NexGenEsisfranchising.comDisclaimer

Loading preview...

Unlock FDD download

Download this + 1,700 other FDDs · One-time purchase

Franchise Costs

Franchise Fee
$55,000
Initial Investment
$168,250 – $362,695
Royalty Rate
7.00%
Brand Fund
1.00%
Fixed Monthly Fees
$300 – $300

7% royalty (greater of 7% of gross sales or $500/mo) + 1% brand fund + $300/mo technology fee

Financial Performance


Item 19 Financial Performance

Average Gross Revenue
$178,883
EBITDA Margin
-28%
Average EBITDA
$-49,921

Data Based On: Financial performance data is based on one franchised clinic located in Clearwater, Florida, for the 2024 calendar year.

* All figures for 'Franchised Reporting Group' are directly extracted from Table 2 for the single franchised clinic in Clearwater, Florida. EBITDA margin was calculated by dividing the EBITDA (-$49,921) by the Gross Revenue ($178,883). The best guess profit range is derived from the reported EBITDA (-$49,921) as the high end (less negative) and the Adjusted EBITDA (-$64,254) as the low end (more negative) for this single franchised unit, as Adjusted EBITDA includes additional franchise-related expenses.

Extracted Item 19 Section

Avg. Revenue: $178,883

Unlock financial performance data with full access to 1,700+ franchise reports

Unlock financial performance data

NexGenEsis Healthcare Franchise Analysis

In a market craving non-opioid alternatives to pain management, NexGenEsis Healthcare pitches autologous injections for natural healing in physician-supervised clinics. Item 19 lays bare revenue and earnings from its handful of units, while the FDD hints at hurdles like stagnant expansion and a corporate bankruptcy shadow. Does this 2022-launched brand hold regenerative potential for franchise profits, or is it still seeking its own cure?

Item 7 details a total investment of $168,250 to $362,695, kicked off by a $55,000 franchise fee, with ongoing royalties at 7% of gross sales (or minimum $500 monthly), 1% brand fund, and $300 monthly technology fee. Item 19 discloses average gross revenue of $178,883 across locations, yet EBITDA margins sit at -0% with estimated profits ranging from -$64,254 to -$49,921—signaling consistent losses that demand scrutiny for any buyer. Just 6 franchised outlets complement 8 corporate spots for 14 total, but growth stalled at 11 locations from 2023 to 2024 (+0%), underscoring a tiny footprint since franchising began in 2022 from Houston headquarters.

The system's flexibility shines with standard franchises, medical practice conversions, bolt-on add-ons, and area developments targeting aging boomers and athletes amid regenerative medicine competition. However, a disclosed bankruptcy history and negative Item 19 figures paint a high-risk picture—units aren't profitable, expansion isn't accelerating, and the parent EAD NexGenix LLC oversees a fragile network. Investors chasing healthcare upside must weigh if scaling treatments for neuropathy, weight loss, or ED can flip these reds to black, or if the model needs more time to mature.

Analysis based on the 2025 Franchise Disclosure Document. All figures should be independently verified before making investment decisions.

How NexGenEsis Healthcare Compares

FranchiseInvestmentFeeRoyaltyLocations
NexGenEsis Healthcare
Current
$168K – $363K$55K7.0%6
Gameday Men's Health$225K – $410K$50K6.0%257
ELLIE MENTAL HEALTH$392K – $680K$60K7.5%255
ASSISTING HANDS (UNIT)$98K – $181K$55K5.0%232
Interim Healthcare$156K – $239K$75K5.5%226
Vital Care$556K – $1.0M$60K19.3%108
Healthcare Services Average
24 franchises
$217K – $492K$58K6.8%

* Comparison based on latest FDD filings. Investment ranges from Item 7, fees from Item 5. Showing top 5 of 24 Healthcare Services franchises by location count.

Locations & Growth


Outlet Growth Over Time

Total outlets at end of each year

Geographic Distribution (2024)

Outlets by state across the United States

Top States
1HI
4
2TX
3
3MS
1
4FL
1
5OH
1
6PA
1
7AZ
0
8LA
0

Unlock location growth data with full access to 1,700+ franchise reports

Unlock location growth data

Franchisee Contacts

13 franchisee contacts on file from official FDD filings.

13 Contacts Available

Unlock all NexGenEsis Healthcare franchisee contacts with verified contact information

Unlock contacts

Due Diligence


Litigation (Item 3)

Franchisee Cases0
No litigation involving franchisees reported

Bankruptcy (Item 4)

Bankruptcy HistoryYes

Chief Development and Sales Officer Nathanael Job Millhouse filed Chapter 13 on January 6, 2017 (completed April 14, 2022, discharged May 16, 2022).

System Health (Item 20)

Franchise system changes reported in the most recent fiscal year

Terminations
0
Non-Renewals
0
Reacquired
0
Ceased Ops
1
Transfers
0
Sold to Franchisees
0
Projected New
0

Unlock due diligence reports with full access to 1,700+ franchise reports

Unlock due diligence reports

Frequently Asked Questions

The total initial investment to open a NexGenEsis Healthcare franchise ranges from $168,250 to $362,695. This includes a franchise fee of $55,000. Ongoing royalty fees are 7.0% of gross sales.